« Back
Home /
Crizotinib (PF-02341066)

Crizotinib (PF-02341066)

Item no.	M1765-100mg
Manufacturer	AbMole
CASRN	877399-52-5
Amount	100mg
Category	Oncology Neuroscience Molecular Targets for Neuroscience Inhibitors & Compound Libraries Small Molecules By Organ Skin Cancer Lymphatic System Cancer
Type	Inhibitors
Specific against	other
Purity	0,9989
ECLASS 10.1	32160490
ECLASS 11.0	32160490
UNSPSC	12000000
Alias	Crizotinib
Similar products	PF-2341066, Crizotinib
Available
Molecular Weight	450, 34
Solubility	DMSO 11 mg/mL
Bioactivity information	Crizotinib (PF-02341066) is a potent, orally bioavailable, ATP-competitive small-molecule inhibitor of c-Met kinase and ALK (anaplastic lymphoma kinase) with IC50 values to be 4 and 25 nM for C-Met and ALK resepectively.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

M1765-100mg-safety-datasheet.pdf